|
2025 Journal Article The Impact of Multidisciplinary Research on Progress in Skin Cancer PreventionSusanto, Alyssa, Primiero, Clare, Goldinger, Simone M., Soyer, H. Peter and Janda, Monika (2025). The Impact of Multidisciplinary Research on Progress in Skin Cancer Prevention. Cancers, 17 (21) 3473, 3473. doi: 10.3390/cancers17213473 |
|
2025 Journal Article Three-dimensional total body photography enables automated obesity-related comorbidity screening in dermatologySusanto, Alyssa, Kahler, Sam, Dulanjala Sewwandi, M. A. Nayomi, Mothershaw, Adam, Goldinger, Simone M., Mar, Victoria, Janda, Monika, Soyer, H.Peter and Primiero, Clare (2025). Three-dimensional total body photography enables automated obesity-related comorbidity screening in dermatology. Journal of Investigative Dermatology. doi: 10.1016/j.jid.2025.09.001 |
|
2025 Journal Article Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumabvon Bubnoff, Dagmar, Schmitt, Christina, Goldinger, Simone M., Schadendorf, Dirk, Kaehler, Katharina C., Hafner, Christian, Kramer, Nora, Froehlich, Waltraud, Dummer, Reinhard, Berking, Carola, Schliep, Stefan, Kirchberger, Michael C. and Heinzerling, Lucie (2025). Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab. Plos One, 20 (5) e0321937, e0321937. doi: 10.1371/journal.pone.0321937 |
|
2025 Journal Article Efficacy of immune checkpoint inhibitors in advanced mucosal melanoma: A systematic review and meta-analysisPham, James P., Kondo, Mickey, Hurwitz, Joshua, Cosman, Rasha, Goldinger, Simone M., Dummer, Reinhard, Sim, Hao-Wen and Joshua, Anthony M. (2025). Efficacy of immune checkpoint inhibitors in advanced mucosal melanoma: A systematic review and meta-analysis. EJC Skin Cancer, 3 100756, 100756. doi: 10.1016/j.ejcskn.2025.100756 |
|
2024 Journal Article An updated review of immune checkpoint inhibitors in cutaneous oncology: Beyond melanomaPham, James P., Staeger, Ramon, Joshua, Anthony M., Liu, Jia, da Silva, Ines P., Dummer, Reinhard and Goldinger, Simone M. (2024). An updated review of immune checkpoint inhibitors in cutaneous oncology: Beyond melanoma. European Journal of Cancer, 214 115121. doi: 10.1016/j.ejca.2024.115121 |
|
2024 Journal Article Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: a systematic review and meta‐analysisPham, James P., Rodrigues, Anthony, Goldinger, Simone M., Sim, Hao‐Wen and Liu, Jia (2024). Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: a systematic review and meta‐analysis. Experimental Dermatology, 33 (1) e14978, 1-7. doi: 10.1111/exd.14978 |
|
2023 Conference Publication Efficacy of immune checkpoint inhibitors (ICIs) in advanced mucosal melanoma (MM): A systematic review and metaanalysisPham, J. P., Hurwitz, J., Cosman, R., Goldinger, S. M., Sim, H. W., Dummer, R. and Joshua, A. M. (2023). Efficacy of immune checkpoint inhibitors (ICIs) in advanced mucosal melanoma (MM): A systematic review and metaanalysis. Congress of the European-Society-for-Medical-Oncology (ESMO), Madrid Spain, Oct 20-24, 2023. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2023.09.2261 |
|
2023 Journal Article Chemotherapy in Cutaneous Melanoma: Is There Still a Role?Pham, James P., Joshua, Anthony M., da Silva, Ines P., Dummer, Reinhard and Goldinger, Simone M. (2023). Chemotherapy in Cutaneous Melanoma: Is There Still a Role?. Current Oncology Reports, 25 (6), 609-621. doi: 10.1007/s11912-023-01385-6 |
|
2022 Journal Article Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysisGoldinger, Simone M., Buder-Bakhaya, Kristina, Lo, Serigne N., Forschner, Andrea, McKean, Meredith, Zimmer, Lisa, Khoo, Chloe, Dummer, Reinhard, Eroglu, Zeynep, Buchbinder, Elizabeth I., Ascierto, Paolo A., Gutzmer, Ralf, Rozeman, Elisa A., Hoeller, Christoph, Johnson, Douglas B., Gesierich, Anja, Kölblinger, Peter, Bennannoune, Naima, Cohen, Justine V., Kähler, Katharina C., Wilson, Melissa A., Cebon, Jonathan, Atkinson, Victoria, Smith, Jessica L., Michielin, Olivier, Long, Georgina V., Hassel, Jessica C., Weide, Benjamin, Haydu, Lauren E. ... Menzies, Alexander M. (2022). Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. European Journal of Cancer, 162, 22-33. doi: 10.1016/j.ejca.2021.11.022 |
|
2022 Journal Article Merkel cell carcinoma in situ: a systematic review of prognosis and managementTruong, Kelvin, Goldinger, Simone M., Chou, Shaun, Howle, Julie R., Veness, Michael J., Fernandez‐Peñas, Pablo and Varey, Alexander H. R. (2022). Merkel cell carcinoma in situ: a systematic review of prognosis and management. Australasian Journal of Dermatology, 63 (1), e6-e12. doi: 10.1111/ajd.13758 |
|
2021 Journal Article Toxic epidermal necrolysis-like lupus erythematosus: a condition to exclude in all patients with possible Stevens-Johnson syndrome/toxic epidermal necrolysisTruong, K., Goldinger, S., Kim, J., Smith, A. and Fernandez-Penas, P. (2021). Toxic epidermal necrolysis-like lupus erythematosus: a condition to exclude in all patients with possible Stevens-Johnson syndrome/toxic epidermal necrolysis. Journal of the European Academy of Dermatology and Venereology, 36 (3), E218-E221. doi: 10.1111/jdv.17753 |
|
2021 Journal Article Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibitionKnispel, Sarah, Gassenmaier, Maximilian, Menzies, Alexander M., Loquai, Carmen, Johnson, Douglas B., Franklin, Cindy, Gutzmer, Ralf, Hassel, Jessica C., Weishaupt, Carsten, Eigentler, Thomas, Schilling, Bastian, Schummer, Patrick, Sirokay, Judith, Kiecker, Felix, Owen, Carina N., Fleischer, Maria, Cann, Christopher, Kaehler, Katharina C., Mohr, Peter, Bluhm, Leonie, Niebel, Dennis, Thoms, Kai-Martin, Goldinger, Simone M., Reinhardt, Lydia, Meier, Friedegund, Berking, Carola, Reinhard, Raphael, Susok, Laura, Ascierto, Paolo A. ... Zimmer, Lisa (2021). Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition. European Journal of Cancer, 148, 61-75. doi: 10.1016/j.ejca.2021.01.034 |
|
2020 Journal Article Long-term response to intermittent binimetinib in patients with NRAS-mutant melanomaMatter, Alexandra Valeska, Micaletto, Sara, Urner-Bloch, Ursula, Dummer, Reinhard and Goldinger, Simone M. (2020). Long-term response to intermittent binimetinib in patients with NRAS-mutant melanoma. Oncologist, 25 (11), E1593-E1597. doi: 10.1634/theoncologist.2019-0656 |
|
2020 Journal Article Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma (vol 25, pg 1915, 2019)Liu, David, Schilling, Bastian, Liu, Derek, Sucker, Antje, Livingstone, Elisabeth, Jerby-Arnon, Livnat, Zimmer, Lisa, Gutzmer, Ralf, Satzger, Imke, Loquai, Carmen, Grabbe, Stephan, Vokes, Natalie, Margolis, Claire A., Conway, Jake, He, Meng Xiao, Elmarakeby, Haitham, Dietlein, Felix, Miao, Diana, Tracy, Adam, Gogas, Helen, Goldinger, Simone M., Utikal, Jochen, Blank, Christian U., Rauschenberg, Ricarda, von Bubnoff, Dagmar, Krackhardt, Angela, Weide, Benjamin, Haferkamp, Sebastian, Kiecker, Felix ... Schadendorf, Dirk (2020). Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma (vol 25, pg 1915, 2019). Nature Medicine, 26 (7), 1147-1147. doi: 10.1038/s41591-020-0975-4 |
|
2019 Journal Article Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaLiu, David, Schilling, Bastian, Liu, Derek, Sucker, Antje, Livingstone, Elisabeth, Jerby-Amon, Livnat, Zimmer, Lisa, Gutzmer, Ralf, Satzger, Imke, Loquai, Carmen, Grabbe, Stephan, Vokes, Natalie, Margolis, Claire A., Conway, Jake, He, Meng Xiao, Elmarakeby, Haitham, Dietlein, Felix, Miao, Diana, Tracy, Adam, Gogas, Helen, Goldinger, Simone M., Utikal, Jochen, Blank, Christian U., Rauschenberg, Ricarda, von Bubnoff, Dagmar, Krackhardt, Angela, Weide, Benjamin, Haferkamp, Sebastian, Kiecker, Felix ... Schadendorf, Dirk (2019). Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nature Medicine, 25 (12), 1916-1927. doi: 10.1038/s41591-019-0654-5 |
|
2019 Journal Article Binimetinib in heavily pretreated patients with NRAS‐mutant melanoma with brain metastasesGoldinger, S. M., Valeska Matter, A., Urner‐Bloch, U., Narainsing, J., Micaletto, S., Blume, I., Mangana, J. and Dummer, R. (2019). Binimetinib in heavily pretreated patients with NRAS‐mutant melanoma with brain metastases. British Journal of Dermatology, 182 (2), 488-490. doi: 10.1111/bjd.18449 |
|
2019 Journal Article A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitisJohnson, Douglas B., McDonnell, Wyatt J., Gonzalez-Ericsson, Paula I., Al-Rohil, Rami N., Mobley, Bret C., Salem, Joe-Elie, Wang, Daniel Y., Sanchez, Violeta, Wang, Yu, Chastain, Cody A., Barker, Kristi, Liang, Yan, Warren, Sarah, Beechem, Joseph M., Menzies, Alexander M., Tio, Martin, Long, Georgina V., Cohen, Justine V., Guidon, Amanda C., O'Hare, Meabh, Chandra, Sunandana, Chowdhary, Akansha, Lebrun-Vignes, Benedicte, Goldinger, Simone M., Rushing, Elisabeth J., Buchbinder, Elizabeth I., Mallal, Simon A., Shi, Chanjuan, Xu, Yaomin ... Balko, Justin M. (2019). A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis. Nature Medicine, 25 (8), 1243-1250. doi: 10.1038/s41591-019-0523-2 |
|
2019 Journal Article Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanomaJansen, Y. J. L., Rozeman, E. A., Mason, R., Goldinger, S. M., Foppen, M. H. Geukes, Hoejberg, L., Schmidt, H., van Thienen, J., Haanen, J. B. A. G., Tiainen, L., Svane, I. M., Makela, S., Seremet, T., Arance, A., Dummer, R., Bastholt, L., Nyakas, M., Straume, O., Menzies, A. M., Long, G., Atkinson, V., Blank, C. U. and Neyns, B. (2019). Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma. Annals of Oncology, 30 (7), 1154-1161. doi: 10.1093/annonc/mdz110 |
|
2019 Journal Article The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanomaGraf, N. P., Koelblinger, P., Galliker, N., Conrad, S., Barysch, M., Mangana, J., Dummer, R., Cheng, P. F. and Goldinger, S. M. (2019). The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanoma. Journal of the European Academy of Dermatology and Venereology, 33 (4), 686-692. doi: 10.1111/jdv.15363 |
|
2019 Journal Article First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysisSchilling, Bastian, Martens, Alexander, Foppen, Marnix H. Geukes, Gebhardt, Christoffer, Hassel, Jessica C., Rozeman, Elisa A., Gesierich, Anja, Gutzmer, Ralf, Kaehler, Katharina C., Livingstone, Elisabeth, Diamantopoulos, Panagiotis T., Gogas, Helen, Madonna, Gabriele, Ascierto, Paolo A., Goldinger, Simone M., Mangana, Johanna, Garbe, Claus, Schadendorf, Dirk, Blank, Christian and Weide, Benjamin (2019). First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis. Cancer Immunology Immunotherapy, 68 (5), 765-772. doi: 10.1007/s00262-019-02311-1 |
